LabCorp Clinical Trials – Overview
Labcorp, a global life sciences company, engages in various healthcare services, including diagnostics and patient care, with its drug development operations now handled by Fortrea. Its involvement in clinical trials is part of its broader commitment to advancing medical science and improving patient care.
Labcorp’s comprehensive services support the healthcare ecosystem, from diagnostics to patient care. Its role in clinical trials contributes to developing new treatments, aiding healthcare professionals in making informed decisions for managing various diseases.
Labcorp offers a comprehensive range of lab testing services, including doctor-requested testing, R&D laboratory testing, clinical trial lab testing, and self-requested testing.
Labcorp Revolutionizing Clinical Trials
Labcorp employs highly qualified professionals with expertise in various fields, ensuring innovative and effective solutions in healthcare and diagnostics. These are individuals who have in-depth knowledge and expertise in their chosen field. This allows Labcorp to employ top experts who use the latest science and technology to detect, diagnose, treat, and manage some of the world’s top healthcare challenges.
Labcorp is helping to revolutionize healthcare processes across the spectrum of medical care. Fortrea (formerly Labcorp’s drug development division) focuses on developing new treatments for urgent challenges in oncology, neurological disorders (such as Alzheimer’s), liver diseases, and autoimmune conditions. Meanwhile, Labcorp helps people prevent serious ailments and maintain good health through its diagnostic services.
Labcorp operates a vast network of laboratories worldwide, providing extensive testing services for various health conditions and supporting global clinical trials. It performs tests for people worldwide for flu symptoms, seizures, allergies, and heart problems. Those clinical trials in neurology, oncology, kidney disease, fertility, and other areas are now managed by Fortrea, an independent company spun off from Labcorp.
The company’s innovative investments, strategic acquisitions, and expert diagnostic teams have helped solve numerous healthcare concerns worldwide.
Types of Labcorp Clinical Trials
Labcorp’s former clinical development arm (now Fortrea) conducts clinical trials across all phases, including phase-1 studies. These trials test new treatments and medicines across different stages of development to ensure safety and efficacy. They also help researchers decide the best dosage, timing, and administration for a new treatment. Clinical trials also provide insight into how medicine affects and reacts to human physiology.
Labcorp conducts several different types of clinical trials at its laboratories, which include:
1. Bioavailability (BA)
Bioavailability (BA) clinical trials are designed to test the rate and extent to which the body absorbs a drug or is effectively available to the treatment site in the body.
2. Bioequivalence (BE)
Bioequivalence (BE) Phase 1 clinical trials help compare drugs with the same active ingredients in terms of their effect at the same dosage under similar conditions.
3. Drug-Drug Interaction
Drug-to-drug interaction clinical trials aim to determine the effects of modifying a drug when administered with another drug. In these trials, one drug is given alongside another to observe how they interact.
4. First in Human (FIH)
This phase-1 trial is the first time a new drug or treatment is tested in humans.
5. Single Ascending Dose / Multiple Ascending Dose (SAD / MAD)
SAD clinical trials are conducted by administering doses to a small group of subjects. Every member of the group receives either a placebo or a drug. The first group starts with a very low dose, and each following group receives an escalated dose, depending on the safety standards and tolerance to the drug. The dose escalation is stopped when maximum tolerability or safety is reached.
On the other hand, in MAD clinical trials conducted by Labcorp, subjects receive multiple doses of the placebo or drug, rather than just one.
6. Food Effect (FE)
Food effect (FE) LabCorp clinical trials involve assessing the impact of food on the absorption of a drug when it is administered shortly after a meal, compared to fasting conditions.
7. Pharmacodynamics (PD)
Pharmacodynamics (PD) clinical trials aim to study the physiological and biochemical effects of drugs, including their duration of action in the body, therapeutic window, undesirable effects (side effects), and desirable activity (the intended effect of the drug).
8. Pharmacokinetic (PK)
Pharmacokinetic (PK) clinical trials help evaluate how the human body absorbs, distributes, metabolizes, and excretes the drug, as well as how the drug affects the body overall.
Conclusion
Labcorp clinical trials have been pivotal in introducing some of the most advanced and revolutionary findings and solutions to the medical and healthcare industry. To learn more about Labcorp clinical trials, you can check their website at https://www.fortreaclinicaltrials.com/en-us/clinical-research/browse-studies.
See Also
Win Ratio DIAMOND Clinical Trial
Microdosing Mushroom Clinical Trials
